LRRK2 G2019S is the most frequent pathogenic missense mutation, which is thought to confer a toxic gain-of-function in LRRK2 kinase activity and has been strongly implicated in PD pathogenesis and neuronal cell death3–6. This evidence concerns the gene LRRK2 and Parkinson disease.